Claire E. Raphael
Mayo Clinic
Internal medicineSurgeryMagnetic resonance imagingPerfusionBlood flowCardiologyArteryHeart failureCoronary arteriesStenosisHypertrophic cardiomyopathyPercutaneous coronary interventionFibrosisMitraClipPercutaneousIn patientMyocardial infarctionAngiologyMedicineCohortEjection fraction
62Publications
14H-index
565Citations
Publications 61
Newest
#1Madeline WhiteH-Index: 1
Last. Sanjay K PrasadH-Index: 64
view all 0 authors...
Source
INTRODUCTION Heart failure (HF) in hypertrophic cardiomyopathy (HCM) is associated with high morbidity and mortality. Predictors of HF, in particular the role of myocardial fibrosis and microvascular ischemia remain unclear. We assessed the predictive value of cardiovascular magnetic resonance (CMR) for development of HF in HCM in an observational cohort study. METHODS Serial patients with HCM underwent CMR, including adenosine first-pass perfusion, left atrial (LA) and left ventricular (LV) vol...
Source
#1Claire E. Raphael (Mayo Clinic)H-Index: 14
#2Peter O'Kane (Royal Bournemouth Hospital)H-Index: 12
Bifurcation lesions are common and associated with higher risks of major cardiac events and restenosis after percutaneous coronary intervention (PCI). Treatment requires understanding of lesion characteristics, stent design and therapeutic options. We review the evidence for provisional vs 2-stent techniques. We conclude that provisional stenting is suitable for most bifurcation lesions. We detail situations where a 2-stent technique should be considered and the steps for performing each of the ...
Source
#1Claire E. RaphaelH-Index: 14
#2David R. HolmesH-Index: 192
Abstract: Balloon aortic valvuloplasty (BAV) is designed to fissure or fracture the calcified aortic valve and separate fused commissures. The role of BAV depends on the specific clinical setting. It may be used as a definitive therapy in patients with severe aortic stenosis with a congenital bicuspid valve. It may be used as a bridge to transcatheter or surgical aortic valve replacement in degenerative calcific aortic stenosis. Even with contemporary equipment, procedural risks remain at approx...
Source
#1Vanessa L. Kronzer (Mayo Clinic)H-Index: 6
#2Alex D Tarabochia (Mayo Clinic)H-Index: 1
Last. Marysia S. Tweet (Mayo Clinic)H-Index: 23
view all 13 authors...
Abstract Background Case reports and referral-based studies suggest spontaneous coronary artery dissection (SCAD) is associated with autoimmune diseases and causes 2% to 4% of acute coronary syndromes. Objectives This study determined the association of SCAD with autoimmune diseases, together with incidence and recurrence, in a population-based study. Methods This case–control study took place from 1995 to 2018 within the Rochester Epidemiology Project. The study identified cases with SCAD from ...
2 CitationsSource
Last. Mandeep Singh (Mayo Clinic)H-Index: 54
view all 7 authors...
ABSTRACT There are limited data on the prevalence and an outcome of left ventricular (LV) aneurysms following acute myocardial infarction (AMI). Using the National Inpatient Sample during 2000-2017, a retrospective cohort of AMI admissions was evaluated for LV aneurysms. Complications included ventricular arrhythmias, mechanical, cardiac arrest, pump failure, LV thrombus, and stroke. Outcomes of interest included in-hospital mortality, temporal trends, complications, hospitalization costs, and l...
1 CitationsSource
#1Claire E. RaphaelH-Index: 14
#2Alphonsus C LiewH-Index: 1
Last. Sanjay K PrasadH-Index: 64
view all 17 authors...
Atrial fibrillation (AF) in hypertrophic cardiomyopathy (HC) is associated with significant symptomatic deterioration, heart failure and thromboembolic disease. There is a need for better mechanistic insight and improved identification of at risk patients. We used CMR to assess predictors of AF in HC, in particular the role of myocardial fibrosis. Consecutive patients with HC referred for CMR 2003-2013 were prospectively enrolled. CMR parameters including left ventricular volumes, presence and p...
1 CitationsSource
#1Claire E. Raphael (Mayo Clinic)H-Index: 14
#2Véronique L. Roger (Mayo Clinic)H-Index: 126
Last. Rajiv Gulati (Mayo Clinic)H-Index: 45
view all 5 authors...
Source
#1Claire E. Raphael (Mayo Clinic)H-Index: 14
#2Véronique L. Roger (Mayo Clinic)H-Index: 126
Last. Rajiv Gulati (Mayo Clinic)H-Index: 45
view all 12 authors...
Background: Type 2 myocardial infarction (T2MI) occurs due to an acute imbalance in myocardial oxygen supply and demand in the absence of athero-thrombosis. Despite being frequently encountered in ...
17 CitationsSource
#1Claire E. RaphaelH-Index: 14
#2Abdallah El-Sabbagh (Mayo Clinic)H-Index: 2
Last. Abhiram Prasad (Mayo Clinic)H-Index: 67
view all 5 authors...
Abstract Mortality from coronary artery disease, the leading cause of death globally, has been on the decline. Percutaneous coronary intervention, performed for over 40 years, has been a major contributor to this favorable trend, together with advances in surgical revascularization, adjunctive pharmacotherapy and risk factor modification. In this chapter, we provide an overview of percutaneous coronary interventions, focusing on the iterative development of devices that have facilitated treatmen...
Source